David R. Kronenthal - Concepedia

Concepedia

Author

David R. Kronenthal

Bristol-Myers Squibb (United States)

Also Known As

D. KRONENTHAL, D. Kronenthal, D. R. KRONENTHAL, D.R Kronenthal, D.R. Kronenthal, David Kronenthal, David R. Kronenthal, Kronenthal, D.R.

46

Publications

1.1K

Citations

18

H-Index

31

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Bristol-Myers Squibb (Sweden)

DR

About

David R. Kronenthal is an author at Bristol-Myers Squibb (United States) specializing in organic chemistry, chemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	11	11	543
2	Natural Sciences	10	10	488
3	Engineering	8	8	514
4	Medicine	8	8	304
5	Biomolecular Engineering	6	6	252

David R. Kronenthal

×

23

Publications

1.1K

Citations

18

H-Index

	Year	Citations
Oxidative N-dearylation of 2-azetidinones. p-Anisidine as a source of azetidinone nitrogen David R. Kronenthal, Cai Yun Han, Martha K. Taylor The Journal of Organic Chemistry Oxidative N-dearylationBioorganic ChemistryEngineeringBiochemistryDonut Icon	1982	242
Enzymatic synthesis of l-6-hydroxynorleucine Ronald L. Hanson, Mark D. Schwinden, Amit Banerjee, Bioorganic & Medicinal Chemistry	1999	88
Cupric bromide mediated oxidation of 4-carboxyoxazolines to the corresponding oxazoles Joel C. Barrish, Janak Singh, Steven H. Spergel, The Journal of Organic Chemistry Cupric BromideHeterocyclicDonut IconAltmetric Attention ScoreOrganic Chemistry	1993	70
One-Carbon Chain Extension of Esters to α-Chloroketones: A Safer Route without Diazomethane Dengjin Wang, Mark D. Schwinden, Lilian Radesca, The Journal of Organic Chemistry Derivative (Chemistry)Enantioselective SynthesisEngineeringPharmaceutical ChemistryMedicine	2004	70
Process Research and Development for an Efficient Synthesis of the HIV Protease Inhibitor BMS-232632 Zhongmin Xu, Janak Singh, Mark D. Schwinden, Organic Process Research & Development EngineeringOrganic ChemistryEfficient SynthesisHuman Immunodeficiency VirusPharmaceutical Chemistry	2002	63
Scalable Synthesis of the Potent HIV Inhibitor BMS‐986001 by Non‐Enzymatic Dynamic Kinetic Asymmetric Transformation (DYKAT) Adrian Ortiz, Tamas Benkovics, Gregory L. Beutner, Angewandte Chemie International Edition Selective PyranoseOrganic ChemistryChemistryPharmaceutical ChemistryScalable Synthesis	2015	57
Synthesis of 6-Cyano-2,2-dimethyl-2H-1-benzopyran and Other Substituted 2,2-Dimethyl-2H-1-benzopyrans Jeffrey T. North, David R. Kronenthal, Annie Pullockaran, The Journal of Organic Chemistry Derivative (Chemistry)DerivativesHeterocyclicDonut IconAltmetric Attention Score	1995	56
4-Alkylated monobactams C. M. CIMARUSTI, D P Bonner, H. Breuer, Tetrahedron	1983	53
Stereospecific friedel-crafts alkylation of benzene with 4-mesyloxy-L-prolines. A new synthesis of 4-phenylprolines David R. Kronenthal, Richard H. Mueller, P. L. KUESTER, Tetrahedron Letters EngineeringStereospecific Friedel-crafts AlkylationOrganic ChemistryNew SynthesisStereoselective Synthesis	1990	41
A Stereoselective Synthesis of BMS-262084, an Azetidinone-Based Tryptase Inhibitor Xinhua Qian, Bin Zheng, Brian Burke, The Journal of Organic Chemistry Combinatorial ChemistryMedicinal ChemistryBiochemistryMedicineNatural Sciences	2002	37

Page 1